儿童期造血干细胞移植后的妊娠与妊娠结局:EBMT儿童疾病工作组横断面调查
99例提供首次妊娠详情,女性分娩或终止妊娠中位年龄23.0岁,移植后中位时间10.7年。女性70次妊娠中63次活产(90%),49/63足月(84.5%),43/46正常出生体重(93%)。
要点
- 儿童期移植后仍可能自然或经辅助生殖妊娠,即使接受清髓性预处理。
- 无TBI预处理女性自然受孕率96%(50/52),TBI组为52%(13/25)。
- TBI预处理男性均需辅助受精或使用冻存精子实现父育。
核心结论
- 儿童或青少年期接受HCT后仍可能实现妊娠,部分需生殖医学支持。
- 移植后女性分娩年龄较健康女性早约5年(平均24.3岁 vs 29岁)。
研究设计与样本
- 回顾性研究,基于EBMT登记库1995-2016年首次HCT的<18岁患者。
主要发现
- 移植时中位年龄15.7岁(范围0.7-18),报告受孕中位年龄25.0岁(范围16.3-38.8)。
- 女性分娩或终止妊娠中位年龄23.0岁(IQR 20.8-27),移植后中位时间10.7年(IQR 6.6-15.4)。
- 无TBI预处理女性自然受孕50/52(96%),TBI组13/25(52%)。
- 女性妊娠活产63/70(90%),足月49/63(84.5%),正常出生体重43/46(93%)。
- 剖宫产9/61(15%),尤其见于接受清髓性预处理者。
临床怎么用
- 对年轻移植患者应进行生殖健康监测和生育力保存咨询。
- 存在自然受孕或经生殖医学支持受孕的机会窗口。
局限性
- EBMT儿童数据集中75%患者末次随访或死亡时年龄<17岁,需更长随访计算累积妊娠率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are the characteristics of patients with conceptions transplanted in childhood and adolescence? SUMMARY ANSWER: Insemination and conception after hematopoietic stem cell transplantation (HCT) in childhood or adolescence was possible, even after myeloablative conditioning regimes, although some patients required reproductive medicine support. WHAT IS KNOWN ALREADY: Preparative regimens of HCT are highly gonadotoxic, which leads to gonadal failure and pubertal development disorders. There are few population-based studies assessing the risk of future infertility in children after HCT. STUDY DESIGN, SIZE, DURATION: We conducted a retrospective study to investigate natural or assisted conceptions and their outcomes in patients <18 years old before their first transplantation who received HCT between 1995 and 2016 and were in the European Society for Blood and Marrow Transplantation (EBMT) registry. Adoptions were excluded from the analysis. PARTICIPANTS/MATERIALS, SETTING, METHODS: Detailed information concerning pregnancy occurrences and outcomes were obtained by a separate questionnaire. Quantitative variables were presented as medians with their interquartile range (IQR) or range, and categorical variables were presented as frequencies and percentages. MAIN RESULTS AND THE ROLE OF CHANCE: In total, 62 988 pediatric patients received a first HCT in EBMT centers between 1995 and 2016. Pregnancy was reported in 406 patients in the database. The median age at transplantation was 15.7 (range: 0.7-18) years, and the median age at declared conception was 25.0 (range: 16.3-38.8) years. Details concerning the first pregnancy and pregnancy outcome were obtained from 99 patients (24%) from the returned questionnaires. The median age at delivery or pregnancy interruption of the females was 23.0 (IQR: 20.8-27) years, with a median time after transplant of 10.7 (IQR: 6.6-15.4) years. Compared with the mean age of healthy women at their first child's birth (29 years old), the transplanted women delivered 5 years earlier (mean: 24.3 years). In terms of conception modality, 13/25 (52%) females conditioned with total body irradiation (TBI) and 50/52 (96%) of those conditioned without TBI conceived naturally. All seven male patients who had been conditioned with TBI achieved fatherhood but required assisted fertilization or used their cryopreserved sperm. In the females, 63/70 (90%) of all conceptions resulted in a live birth, 49/63 (84.5%) were at term and 43/46 (93%) had normal birthweight. Cesarean delivery was performed in 9/61 (15%) especially in women who had received a myeloablative regimen. LIMITATIONS, REASONS FOR CAUTION: In the EBMT pediatric dataset, the age at last follow-up or death was <17 years for 75% of the patients, therefore a longer follow-up for all patients would be necessary to calculate the cumulative incidence of conception for patients transplanted during childhood and allow all patients to realize their reproductive willingness/potential. WIDER IMPLICATIONS OF THE FINDINGS: Reproductive health surveillance and fertility preservation counseling are important in younger transplanted patients. Our results showed that there is a window of opportunity to conceive naturally or with reproductive medicine support. STUDY FUNDING/COMPETING INTEREST(S): Funding was provided by the 'Stiftung für krebskranke Kinder Regio Basiliensis', Basel, Switzerland. All authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Diesch-Furlanetto T, Rovó A, Galimard JE, et al. Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party. Hum Reprod. 2021. PMID: 34529796. doi:10.1093/humrep/deab199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。